Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.6736
-0.0274 (-3.91%)
May 12, 2025, 3:53 PM - Market open

Lexicon Pharmaceuticals Market Cap

Lexicon Pharmaceuticals has a market cap or net worth of $243.03 million as of May 12, 2025. Its market cap has decreased by -38.32% in one year.

Market Cap
243.03M
Enterprise Value
117.57M
1-Year Change
-38.32%
Ranking
Category
Stock Price
$0.67

Market Cap Chart

Since April 7, 2000, Lexicon Pharmaceuticals's market cap has decreased from $890.90M to $243.03M, a decrease of -72.72%. That is a compound annual growth rate of -5.04%.

History

DateMarket Cap% Change
May 9, 2025253.40M-5.13%
Dec 31, 2024267.10M-28.72%
Dec 29, 2023374.70M3.94%
Dec 30, 2022360.50M-38.54%
Dec 31, 2021586.60M45.99%
Dec 31, 2020401.80M-8.89%
Dec 31, 2019441.00M-37.30%
Dec 31, 2018703.30M-32.58%
Dec 29, 20171.04B-27.50%
Dec 30, 20161.44B4.32%
Dec 31, 20151.38B194.45%
Dec 31, 2014468.40M-49.30%
Dec 31, 2013923.80M-18.41%
Dec 31, 20121.13B159.94%
Dec 30, 2011435.60M-10.39%
Dec 31, 2010486.10M62.74%
Dec 31, 2009298.70M55.98%
Dec 31, 2008191.50M-53.80%
Dec 31, 2007414.50M50.51%
Dec 29, 2006275.40M16.89%
Dec 30, 2005235.60M-52.10%
Dec 31, 2004491.90M33.02%
Dec 31, 2003369.80M49.35%
Dec 31, 2002247.60M-58.67%
Dec 31, 2001599.10M-25.13%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 677.07B
Johnson & Johnson 373.71B
UnitedHealth Group 344.57B
AbbVie 339.01B
Novo Nordisk 297.79B
Abbott Laboratories 232.22B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings